Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
TENX
Tenax Therapeutics, Inc.
NASDAQCM
Biotechnology
United States
$1.94
▲
+0.16 (+8.99%)
CLOSED
—
OPEN
$1.82
HIGH
$1.96
LOW
$1.80
PREV CLOSE
$1.78
VOLUME
4.38M
0.89x avg
BID / ASK
1.38 / 2.34
spr 0.960
MARKET CAP
$72.6M
DAY RANGE
$1.80
$1.96
P/E (TTM)
—
Fwd -1.3
EPS (TTM)
-1.61
DIV YIELD
—
52W HIGH
$19.40
-90.0%
52W LOW
$1.31
+48.1%
BETA
0.82
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$1.92
-0.02
(-1.03%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
TENX
$1.94
▲
+8.99%
Chart
Valuation
Financials
Peers
News
TENX · K 線技術分析（即時、可互動）
basic
pro
快速分析（2–5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，一般約 2 分鐘，上游壅塞時最長約 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-OFF
252 BARS · -67.6% YOY
1-year price chart. Started at 5.99, currently 1.94, down 67.6 percent. Range 1.38 to 18.32 over 252 data points.
2025-09-05
$5.99 → $1.94 (-67.6%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$3.36
WACC Used
+7.0%
Terminal g
+3.5%
判定: sell
· peers $3.36 (+73.0%)
同業:
SERA
GANX
DWTX PE1
RNTX
SPRO PE9
FRMM
SER
PMVP
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
多年財務（SEC XBRL）
—
3 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$0.00
-$52.6M
-$35.8M
—
$104.2M
2024-12
$0.00
-$17.6M
-$14.8M
—
$96.7M
2023-12
—
-$7.7M
-$5.9M
—
$11.7M
PEERS
同業與產業對照
CALM
10 PEERS · FINNHUB
SERA
GANX
DWTX
RNTX
SPRO
FRMM
SER
PMVP
XBIT
INMB
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?
Insider Monkey · 2026-09-04
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire · 2026-09-01
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · 2026-08-31
Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy
MT Newswires · 2026-08-31
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
GlobeNewswire · 2026-08-29
Chardan Downgrades Tenax Therapeutics to Neutral From Buy, Adjusts Price Target to $5 From $27
MT Newswires · 2026-08-11
Evercore ISI Downgrades Tenax Therapeutics to In Line From Outperform, Adjusts PT to $5 From $39
MT Newswires · 2026-08-11
Tenax Therapeutics’ stock crashes on Phase III trial failure
Clinical Trials Arena · 2026-08-11